New ultrasound technique could spot eye tumors without a biopsy
NCT ID NCT05051384
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a special ultrasound technique called Superb Microvascular Imaging (SMI) to see blood flow inside eye tumors. The goal is to help doctors tell benign from malignant tumors more accurately, especially when standard tests are unclear. Twenty-two adults with untreated eye tumors will be scanned before proton therapy to see if SMI improves diagnosis.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Doppler technology (Superb Microvascular Imaging)
- What this could lead to
- If successful, this imaging technique could help doctors more accurately diagnose eye tumors as benign or malignant, potentially reducing the need for invasive biopsies.
- What could go wrong
- This is a small, early-stage study with only 22 participants, so results may not apply to all patients. The technique may not clearly distinguish tumor types in all cases.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OCULAR TUMOR are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU de Nice
Nice, France, 06000, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.